{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:09:11Z","timestamp":1790208551346,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060442"],"award-info":[{"award-number":["82060442"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460151"],"award-info":[{"award-number":["82460151"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guizhou Provincial Science and Technology Projects","award":["qkhjc-ZK[2024]YB-238"],"award-info":[{"award-number":["qkhjc-ZK[2024]YB-238"]}]},{"name":"Science and Technology Foundation of Guizhou Provincial Health Commission","award":["gzwkj2024-313"],"award-info":[{"award-number":["gzwkj2024-313"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07721-1","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:35:09Z","timestamp":1769520909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting super-enhancer-driven SKIL transcription by CDK7 inhibitor THZ1 to suppress gastric cancer progression"],"prefix":"10.1186","volume":"24","author":[{"given":"Bingxue","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingwei","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhui","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"7721_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.molcel.2009.04.016","volume":"34","author":"MS Akhtar","year":"2009","unstructured":"Akhtar MS, Heidemann M, Tietjen JR, Zhang DW, Chapman RD, Eick D, et al. TFIIH kinase places bivalent marks on the carboxy-terminal domain of RNA polymerase II. Mol Cell. 2009;34:387\u201393.","journal-title":"Mol Cell"},{"key":"7721_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10555-023-10103-4","volume":"42","author":"M Bacabac","year":"2023","unstructured":"Bacabac M, Xu W. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets. Cancer Metastasis Rev. 2023;42:471\u201380.","journal-title":"Cancer Metastasis Rev"},{"key":"7721_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/neuonc\/noad143","volume":"26","author":"I Bhutada","year":"2024","unstructured":"Bhutada I, Khambati F, Cheng SY, Tiek DM, Duckett D, Lawrence H, et al. CDK7 and CDK9 Inhibition interferes with transcription, translation, and stemness, and induces cytotoxicity in GBM irrespective of Temozolomide sensitivity. Neuro Oncol. 2024;26:70\u201384.","journal-title":"Neuro Oncol"},{"key":"7721_CR4","first-page":"629","volume":"168","author":"JE Bradner","year":"2017","unstructured":"Bradner JE, Hnisz D, Young RA. Transcriptional Addict Cancer Cell. 2017;168:629\u201343.","journal-title":"Transcriptional Addict Cancer Cell"},{"key":"7721_CR5","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"7721_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1593\/neo.03442","volume":"6","author":"M Buess","year":"2004","unstructured":"Buess M, Terracciano L, Reuter J, Ballabeni P, Boulay JL, Laffer U, et al. Amplification of SKI is a prognostic marker in early colorectal cancer. Neoplasia. 2004;6:207\u201312.","journal-title":"Neoplasia"},{"key":"7721_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ccell.2020.08.020","volume":"38","author":"H Chen","year":"2020","unstructured":"Chen H, Liang H. A High-Resolution map of human enhancer RNA loci characterizes Super-enhancer activities in cancer. Cancer Cell. 2020;38:701\u2013e715705.","journal-title":"Cancer Cell"},{"key":"7721_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41419-023-05892-z","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, Tian D, Chen X, Cheng M, Xie H, Zhao J, et al. Super-enhancer-driven LncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression. Cell Death Dis. 2023;14:383.","journal-title":"Cell Death Dis"},{"key":"7721_CR9","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.cell.2014.10.024","volume":"159","author":"E Chipumuro","year":"2014","unstructured":"Chipumuro E, Marco E, Christensen CL, Kwiatkowski N, Zhang T, Hatheway CM, et al. CDK7 Inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell. 2014;159:1126\u201339.","journal-title":"Cell"},{"key":"7721_CR10","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.ccell.2014.10.019","volume":"26","author":"CL Christensen","year":"2014","unstructured":"Christensen CL, Kwiatkowski N, Abraham BJ, Carretero J, Al-Shahrour F, Zhang T, et al. Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell. 2014;26:909\u201322.","journal-title":"Cancer Cell"},{"key":"7721_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/cr.2008.324","volume":"19","author":"J Deheuninck","year":"2009","unstructured":"Deheuninck J, Luo K. Ski and SnoN, potent negative regulators of TGF-beta signaling. Cell Res. 2009;19:47\u201357.","journal-title":"Cell Res"},{"key":"7721_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, Hu Y, Lan T, Guan KL, Luo T, Luo M. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Therapy. 2022;7:376.","journal-title":"Signal Transduct Target Therapy"},{"key":"7721_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41580-022-00476-9","volume":"23","author":"M Girbig","year":"2022","unstructured":"Girbig M, Misiaszek AD, Muller CW. Structural insights into nuclear transcription by eukaryotic DNA-dependent RNA polymerases. Nat Rev Mol Cell Biol. 2022;23:603\u201322.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7721_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"key":"7721_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"7721_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm.2017.10","volume":"18","author":"KM Harlen","year":"2017","unstructured":"Harlen KM, Churchman LS. The code and beyond: transcription regulation by the RNA polymerase II carboxy-terminal domain. Nat Rev Mol Cell Biol. 2017;18:263\u201373.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7721_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"KF Harvey","year":"2013","unstructured":"Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer. 2013;13:246\u201357.","journal-title":"Nat Rev Cancer"},{"key":"7721_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/gutjnl-2021-326483","volume":"72","author":"SWT Ho","year":"2023","unstructured":"Ho SWT, Sheng T, Xing M, Ooi WF, Xu C, Sundar R, et al. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities. Gut. 2023;72:226\u201341.","journal-title":"Gut"},{"key":"7721_CR19","doi-asserted-by":"publisher","first-page":"14744","DOI":"10.1021\/acsnano.1c04570","volume":"15","author":"CS Huang","year":"2021","unstructured":"Huang CS, Xu QC, Dai C, Wang L, Tien YC, Li F, et al. Nanomaterial-Facilitated Cyclin-Dependent kinase 7 Inhibition suppresses gallbladder cancer progression via targeting transcriptional addiction. ACS Nano. 2021;15:14744\u201355.","journal-title":"ACS Nano"},{"key":"7721_CR20","doi-asserted-by":"publisher","first-page":"108489","DOI":"10.1016\/j.mrrev.2024.108489","volume":"793","author":"Y Huang","year":"2024","unstructured":"Huang Y, Huo Y, Huang L, Zhang L, Zheng Y, Zhang N, et al. Super-enhancers: implications in gastric cancer. Mutat Res Rev Mutat Res. 2024;793:108489.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"7721_CR21","doi-asserted-by":"publisher","first-page":"e55794","DOI":"10.1371\/journal.pone.0055794","volume":"8","author":"NS Jahchan","year":"2013","unstructured":"Jahchan NS, Ouyang G, Luo K. Expression profiles of SnoN in normal and cancerous human tissues support its tumor suppressor role in human cancer. PLoS ONE. 2013;8:e55794.","journal-title":"PLoS ONE"},{"key":"7721_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12967-025-06098-x","volume":"23","author":"Y Ji","year":"2025","unstructured":"Ji Y, Li B, Lin R, Yuan J, Han Y, Du Y, et al. Super-enhancers in tumors: unraveling recent advances in their role in oncogenesis and the emergence of targeted therapies. J Transl Med. 2025;23:98.","journal-title":"J Transl Med"},{"key":"7721_CR23","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/gutjnl-2016-311818","volume":"66","author":"YY Jiang","year":"2017","unstructured":"Jiang YY, Lin DC, Mayakonda A, Hazawa M, Ding LW, Chien WW, et al. Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma. Gut. 2017;66:1358\u201368.","journal-title":"Gut"},{"key":"7721_CR24","doi-asserted-by":"crossref","unstructured":"Ju J, Zhang H, Lin M, Yan Z, An L, Cao Z, et al. The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer. J Clin Invest. 2024;134.","DOI":"10.1172\/JCI174587"},{"key":"7721_CR25","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1038\/s44318-024-00085-6","volume":"43","author":"O Jung","year":"2024","unstructured":"Jung O, Baek MJ, Wooldrik C, Johnson KR, Fisher KW, Lou J, et al. Nuclear phosphoinositide signaling promotes YAP\/TAZ-TEAD transcriptional activity in breast cancer. EMBO J. 2024;43:1740\u201369.","journal-title":"EMBO J"},{"key":"7721_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5483\/BMBRep.2018.51.3.015","volume":"51","author":"MK Kim","year":"2018","unstructured":"Kim MK, Jang JW, Bae SC. DNA binding partners of YAP\/TAZ. BMB Rep. 2018;51:126\u201333.","journal-title":"BMB Rep"},{"key":"7721_CR27","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nature13393","volume":"511","author":"N Kwiatkowski","year":"2014","unstructured":"Kwiatkowski N, Zhang T, Rahl PB, Abraham BJ, Reddy J, Ficarro SB, et al. Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature. 2014;511:616\u201320.","journal-title":"Nature"},{"key":"7721_CR28","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/nsmb.2399","volume":"19","author":"S Larochelle","year":"2012","unstructured":"Larochelle S, Amat R, Glover-Cutter K, Sanso M, Zhang C, Allen JJ, et al. Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II. Nat Struct Mol Biol. 2012;19:1108\u201315.","journal-title":"Nat Struct Mol Biol"},{"key":"7721_CR29","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","volume":"7","author":"ZN Lei","year":"2022","unstructured":"Lei ZN, Teng QX, Tian Q, Chen W, Xie Y, Wu K, et al. Signaling pathways and therapeutic interventions in gastric cancer. Signal Transduct Target Therapy. 2022;7:358.","journal-title":"Signal Transduct Target Therapy"},{"key":"7721_CR30","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41586-018-0174-3","volume":"558","author":"H Lu","year":"2018","unstructured":"Lu H, Yu D, Hansen AS, Ganguly S, Liu R, Heckert A, et al. Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II. Nature. 2018;558:318\u201323.","journal-title":"Nature"},{"key":"7721_CR31","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/s41419-020-03200-7","volume":"11","author":"F Ma","year":"2020","unstructured":"Ma F, Ding MG, Lei YY, Luo LH, Jiang S, Feng YH, et al. SKIL facilitates tumorigenesis and immune escape of NSCLC via upregulating TAZ\/autophagy axis. Cell Death Dis. 2020;11:1028.","journal-title":"Cell Death Dis"},{"key":"7721_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.canlet.2021.03.006","volume":"507","author":"S Mohajan","year":"2021","unstructured":"Mohajan S, Jaiswal PK, Vatanmakarian M, Yousefi H, Sankaralingam S, Alahari SK, et al. Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer. Cancer Lett. 2021;507:112\u201323.","journal-title":"Cancer Lett"},{"key":"7721_CR33","doi-asserted-by":"publisher","first-page":"12983","DOI":"10.1038\/ncomms12983","volume":"7","author":"WF Ooi","year":"2016","unstructured":"Ooi WF, Xing M, Xu C, Yao X, Ramlee MK, Lim MC, et al. Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity. Nat Commun. 2016;7:12983.","journal-title":"Nat Commun"},{"key":"7721_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.trecan.2017.03.006","volume":"3","author":"S Sengupta","year":"2017","unstructured":"Sengupta S, George RE. Super-Enhancer-Driven transcriptional dependencies in cancer. Trends Cancer. 2017;3:269\u201381.","journal-title":"Trends Cancer"},{"key":"7721_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbrc.2012.11.005","volume":"430","author":"E Shinozuka","year":"2013","unstructured":"Shinozuka E, Miyashita M, Mizuguchi Y, Akagi I, Kikuchi K, Makino H, et al. SnoN\/SKIL modulates proliferation through control of hsa-miR-720 transcription in esophageal cancer cells. Biochem Biophys Res Commun. 2013;430:101\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"7721_CR36","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"7721_CR37","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s43018-021-00240-6","volume":"2","author":"Y Tanaka","year":"2021","unstructured":"Tanaka Y, Chiwaki F, Kojima S, Kawazu M, Komatsu M, Ueno T, et al. Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities. Nat Cancer. 2021;2:962\u201377.","journal-title":"Nat Cancer"},{"key":"7721_CR38","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/j.molcel.2024.05.007","volume":"84","author":"T Velychko","year":"2024","unstructured":"Velychko T, Mohammad E, Ferrer-Vicens I, Parfentev I, Werner M, Studniarek C, et al. CDK7 kinase activity promotes RNA polymerase II promoter escape by facilitating initiation factor release. Mol Cell. 2024;84:2287\u2013e23032210.","journal-title":"Mol Cell"},{"key":"7721_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13046-023-02870-3","volume":"42","author":"T Wang","year":"2023","unstructured":"Wang T, Wang D, Sun Y, Zhuang T, Li X, Yang H, et al. Regulation of the Hippo\/YAP axis by CXCR7 in the tumorigenesis of gastric cancer. J Exp Clin Cancer Res. 2023;42:297.","journal-title":"J Exp Clin Cancer Res"},{"key":"7721_CR40","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12967-025-06270-3","volume":"23","author":"Y Xi","year":"2025","unstructured":"Xi Y, Wang R, Qu M, Pan Q, Wang M, Ai X, et al. Super-enhancer-hijacking RBBP7 potentiates metastasis and stemness of breast cancer via recruiting NuRD complex subunit LSD1. J Transl Med. 2025;23:266.","journal-title":"J Transl Med"},{"key":"7721_CR41","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1038\/s41467-019-09644-6","volume":"10","author":"R Xing","year":"2019","unstructured":"Xing R, Zhou Y, Yu J, Yu Y, Nie Y, Luo W, et al. Whole-genome sequencing reveals novel tandem-duplication hotspots and a prognostic mutational signature in gastric cancer. Nat Commun. 2019;10:2037.","journal-title":"Nat Commun"},{"key":"7721_CR42","doi-asserted-by":"publisher","first-page":"e56150","DOI":"10.15252\/embr.202256150","volume":"24","author":"Y Yahia","year":"2023","unstructured":"Yahia Y, Pigeot A, El Aabidine AZ, Shah N, Karasu N, Forne I, et al. RNA polymerase II CTD is dispensable for transcription and required for termination in human cells. EMBO Rep. 2023;24:e56150.","journal-title":"EMBO Rep"},{"key":"7721_CR43","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s13402-021-00608-x","volume":"44","author":"Y Yang","year":"2021","unstructured":"Yang Y, Jiang D, Zhou Z, Xiong H, Yang X, Peng G, et al. CDK7 Blockade suppresses super-enhancer-associated oncogenes in bladder cancer. Cell Oncol (Dordr). 2021;44:871\u201387.","journal-title":"Cell Oncol (Dordr)"},{"key":"7721_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13046-022-02443-w","volume":"41","author":"S Zeng","year":"2022","unstructured":"Zeng S, Lan B, Ren X, Zhang S, Schreyer D, Eckstein M, et al. CDK7 Inhibition augments response to multidrug chemotherapy in pancreatic cancer. J Exp Clin Cancer Res. 2022;41:241.","journal-title":"J Exp Clin Cancer Res"},{"key":"7721_CR45","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.semcancer.2021.12.004","volume":"86","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Jin RU. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer. Semin Cancer Biol. 2022;86:566\u201382.","journal-title":"Semin Cancer Biol"},{"key":"7721_CR46","first-page":"5005","volume":"63","author":"F Zhang","year":"2003","unstructured":"Zhang F, Lundin M, Ristimaki A, Heikkila P, Lundin J, Isola J, et al. Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in Estrogen receptor-positive breast carcinomas. Cancer Res. 2003;63:5005\u201310.","journal-title":"Cancer Res"},{"key":"7721_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13045-022-01331-2","volume":"15","author":"T Zhang","year":"2022","unstructured":"Zhang T, Xia W, Song X, Mao Q, Huang X, Chen B, et al. Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-beta\/SMAD3 pathway. J Hematol Oncol. 2022;15:114.","journal-title":"J Hematol Oncol"},{"key":"7721_CR48","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.trecan.2023.07.017","volume":"9","author":"J Zhao","year":"2023","unstructured":"Zhao J, Faryabi RB. Spatial promoter-enhancer hubs in cancer: organization, regulation, and function. Trends Cancer. 2023;9:1069\u201384.","journal-title":"Trends Cancer"},{"key":"7721_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-biochem-052610-095910","volume":"81","author":"Q Zhou","year":"2012","unstructured":"Zhou Q, Li T, Price DH. RNA polymerase II elongation control. Annu Rev Biochem. 2012;81:119\u201343.","journal-title":"Annu Rev Biochem"},{"key":"7721_CR50","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.devcel.2016.05.002","volume":"37","author":"Q Zhu","year":"2016","unstructured":"Zhu Q, Le Scolan E, Jahchan N, Ji X, Xu A, Luo K. SnoN antagonizes the Hippo kinase complex to promote TAZ signaling during breast carcinogenesis. Dev Cell. 2016;37:399\u2013412.","journal-title":"Dev Cell"},{"key":"7721_CR51","doi-asserted-by":"publisher","first-page":"e1621","DOI":"10.1002\/ctm2.1621","volume":"14","author":"S Zou","year":"2024","unstructured":"Zou S, Huang Y, Yang Z, Zhang J, Meng M, Zhang Y, et al. NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization. Clin Transl Med. 2024;14:e1621.","journal-title":"Clin Transl Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07721-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07721-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07721-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:03:15Z","timestamp":1770109395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07721-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7721"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07721-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures involving animals adhered to the National Institutes of Health guidelines and were authorized by the Animal Research Ethics Committee of Guizhou Medical University (approval number 2403428). Informed consent was obtained from all subjects. The study was approved by the Ethics Committee of the Affiliated Hospital of Guizhou Medical University [approval number 2024 (343)].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This work is original and unpublished in any other journal. All co-authors approved this publication, contributed to the research, and report no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}